TAKEDA PHARMACEUTICAL COMPANY LIMITED

ABOSLIX

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases;

ACTOPLUS MET

Anti-diabetics;

ACTOPLUS SULF

Anti-diabetics;SULF;

ACTOS

anti-diabetics;

ACTOS ADVANTAGE

Promoting the sale of anti-diabetic preparations through the administration of incentive award programs;

ACTOS, THE CARDIODIABETES CHOICE

Pharmaceutical preparations, namely, anti-diabetic preparations;

ACTOS, THE CARDIODIABETES DRUG

Pharmaceutical preparations, namely, anti-diabetic preparations;DRUG;

ACTOS, THE CARDIODIABETES OPTION

Pharmaceutical preparations, namely, anti-diabetic preparations;

ACTOSULF

Anti-diabetics;

ACTOZACT

Pharmaceutical preparations for use in the treatment of diabetes; Pharmaceutical preparations for use in the treatment of cardiovascular disorders and cholesterol reduction;

ADROBU

Cardiovascular treatment preparations;

ALOCITY

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

ANOMBRAL

Pharmaceutical preparations for the treatment of diabetic diseases;The wording ANOMBRAL has no meaning in a foreign language.;

APONTA

Pharmaceutical preparations for human use for the treatment of cardiovascular conditions and diseases;

ARBTOTA

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders;

AVROLU

Cardiovascular treatment preparations;

AZALMOD

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders;

BALINDAL

Pharmaceutical preparations for the treatment of diabetic diseases;The wording BALINDAL has no meaning in a foreign language.;

BALVAND

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

BAVZED

Cardiovascular treatment preparations;

BETTER HEALTH BRIGHTER FUTURE

Pharmaceutical and veterinary preparations for use in the treatment and prevention of bacterial, cardiovascular, central and peripheral nervous system, diabetic, endocrine, fungal, hormonal, gastrointestinal, immunological, infectious, inflammation and inflammatory, musculoskeletal, neurological, oncological, respiratory, sexual dysfunction, urological, and viral diseases and disorders; sanitary preparations for medical purposes; dietetic substances adapted for medical use; food for babies, materials for dressings, namely, medical plasters; materials for stopping teeth, dental wax; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides;Scientific and technological services, namely, scientific research and consultation in the medical and pharmaceutical field, conducting clinical trials for others; industrial analysis and research services in the field of pharmaceutical manufacturing and chemical manufacturing; design and development of computer hardware and software;

BETTER HEALTH, BRIGHTER FUTURE

[ Pharmaceutical preparations for use in the treatment and prevention of bacterial, cardiovascular, central and peripheral nervous system, diabetic, endocrine, fungal, hormonal, gastrointestinal, immunological, infectious, inflammation and inflammatory, musculoskeletal, neurological, oncological, respiratory, sexual dysfunction, urological, and viral diseases and disorders; vaccines ];HEALTH;Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Providing medical clinical trial study of medicines;

BEVIZO

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculosketetal disorders;

BEYASO

In the statement, line 1, PHARMCEUTICAL should be deleted, and PHARMACEUTICAL should be inserted.;Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

BIREPATH

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculosketetal disorders;

BUTURAD

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

BYLIMIR

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;The wording BYLIMIR has no meaning in a foreign language.;

CADESEP

Pharmaceutical preparations for human use for the treatment of severe sepsis;The term CADESEP does not have any significance.;

CALSENA

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

CARDIODIABETES

Pharmaceutical preparations, namely, anti-diabetic preparations;DRUG;

CAVESEP

Pharmaceutical preparations for human use for the treatment of severe sepsis;CAVE SEPSIS;

CE-VAST

Downloadable software for evaluating the severity of celiac disease in patients;Publications and printed materials, namely, brochures, informational flyers, printed guides, printed informational endoscopic images, and posters containing information for evaluating the severity of celiac disease in patients;Medical imaging services; medical screening;Providing temporary use of non-downloadable software for evaluating the severity of celiac disease in patients;

CE-VAST

Downloadable software for evaluating the severity of celiac disease in patients;Publications and printed materials, namely, brochures, informational flyers, printed guides, printed informational endoscopic images, and posters containing information for evaluating the severity of celiac disease in patients;Medical imaging services; medical screening;Providing temporary use of non-downloadable software for evaluating the severity of celiac disease in patients;

CEDEPSA

Pharmaceutical preparations for the treatment of severe sepsis;

CELPERIA

Anti-diabetic preparations;

CEVELT

Pharmaceutical preparations for human use for the treatment of cardiovascular conditions and diseases;

CHANGING THE FUTURE OF HEALTH

Pharmaceutical, veterinary and sanitary preparations;Clinical testing of pharmaceuticals; testing, inspection, analysis, study, research and development of pharmaceuticals; providing information relating to testing, inspection, analysis, study, research and development of pharmaceuticals;

CHLORDARBI

Pharmaceutical preparations for the treatment of cardiovascular disease;

CHLOREDARB

Pharmaceutical preparations for the treatment of cardiovascular disease;

CIRITAS

Pharmaceutical preparations for the treatment of diabetic diseases;The wording CIRITAS has no meaning in a foreign language.;

CLENDEPIV

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

CLENERO

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases;

CLENGANT

Pharmaceutical preparations for the treatment and prevention of diabetic diseases;

CLEZDUO

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders;

CLORDARBI

Pharmaceutical preparations for the treatment of cardiovascular disease;

CLUDARBI

Cardiovascular treatment preparations;

CLUSIVA

Anti-diabetic preparations;

COCKPI-T

In the statement, line 10, JP2015-04137 should be deleted, and JP2015041371 should be inserted.;COCKPIT;Provision of grants for research in the field of pharmaceuticals;Conducting experiments, research and development of pharmaceuticals, and provision of guidance, advice and information related thereto;

COCKPI-T

The mark consists of stylized clasping of two blue-colored hands outlined in white, extending from two round-sleeved arms in blue with white cuffs, all forming a stylized letter C in the center of which is a lit yellow light bulb with a gray base surrounded by gray lines emanating out around the bulb and to the right of the top half of the C are the blue letters O C K P I -T.;COCKPIT;Provision of grants for research in the field of pharmaceuticals;The color(s) blue, white, yellow and gray is/are claimed as a feature of the mark.;Conducting experiments, research and development of pharmaceuticals, and provision of guidance, advice and information related thereto;